Photobiomodulation apparatus, system, and method
The method and system for photobiomodulation through the skull, nose, or eyelid with adjustable light parameters and biological monitoring address the limitations of current myopia treatments, achieving safe and effective myopia control and systemic health benefits.
Patent Information
- Application Number
- PCT/IB2025/000429
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-23
- Filing Date
- 2025-08-25
- Publication Date
- 2026-02-26
AI Technical Summary
Current methods for managing myopia progression, such as optical interventions and light irradiation, often require ongoing compliance and can cause adverse effects like retinal burn or overexposure, and there is a need for safer and more effective photobiomodulation techniques.
A method and system for photobiomodulation that applies light through the skull, nose, or eyelid using LED arrays or halogen lights with adjustable wavelengths, durations, and intensities, combined with biological response monitoring and AI/ML to optimize treatment, avoiding direct eye exposure and enhancing compliance.
This approach safely increases choroidal thickness, decreases eye axial length, and enhances mitochondrial activity, effectively slowing myopia progression while improving physiological performance and treating conditions like Alzheimer's and diabetes.